PubMed Health⌕ Search

PubMed · 2138688

Occupationally related disorders.

Abstract

Occupational disease is responsible each year in the United States for 50,000 to 70,000 deaths and for approximately 350,000 new cases of illness. Occupational diseases affect all organ systems and include pulmonary disease, musculoskeletal injuries, occupational cancer, traumatic injuries, occupationally induced cardiovascular disease, disorders of reproduction, neurotoxic disorders, noise-induced hearing loss, dermatologic conditions, and psychological disorders. Occupational diseases may be very difficult to diagnose. Pathognomonic signs and symptoms are rare; most occupational diseases are clinically indistinguishable from disease of other etiologies. Diagnosis is complicated further by the long latency typical between a toxic occupational exposure and the appearance of illness. Further, there is widespread lack of information on the toxicity of most chemical substances in use in American workplaces, and workers frequently are not informed of the nature or the hazards of the materials with which they work. The occupational history is the principal clinical instrument for the diagnosis of occupational disease. All patients should undergo at least a brief occupational history that inquires about the current job, including both industry and occupation, the longest-held previous jobs, and any toxic occupational exposures to chemicals, fumes, gases, dust, noise, or radiation. Proper diagnosis of occupational disease permits proper treatment of the affected patient and also provides a basis for recognition of other similarly employed persons who may also be at risk of toxic exposure. Occupational diseases are highly preventable. Prevention is most efficiently achieved by removing hazardous materials from the workplace and replacing them with less hazardous substances. Other approaches to prevention include ventilation, alteration in work practices, and use of personal protective equipment. Physicians in the United States are for the most part not well trained to recognize occupational illness. At the same time, there is a great lack of qualified specialists in occupational medicine. The majority of care of patients with occupational disease will therefore continue to be the responsibility of primary care physicians, and these physicians must become more highly attuned to the possibility that their patients may have diseases induced by toxic exposures encountered at work. The development of a heightened sensitivity of primary care providers to occupationally induced disease is an urgent priority.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D B Baker, P J Landrigan. 1990. Occupationally related disorders.. https://doi.org/10.1016/s0025-7125(16)30572-7

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗